Status:
COMPLETED
Use of Midlevel Providers in Diabetes Management
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Studies have demonstrated that intensive disease management of diabetes and its associated risk factors, hypertension and dyslipidemia, can prevent the progression of vascular complications. However, ...
Eligibility Criteria
Inclusion
- Definitive diagnosis of Type II diabetes based on ADA diagnostic criteria.
- All persons with diabetes who do not meet ADA goals for glycemic, blood pressure or lipid control.This includes new or previously diagnosed patients.
- Men and women 21 years of age or older.
- Speaks and reads English
- Willing to participate (informed consent)
Exclusion
- Type I diabetes
- Diagnosis of dementia or mental retardation.
- Resident of personal care home, assisted living, or long term care facility.
- Significant drug/alcohol abuse in the past 18 months.
- Active malignant process including patients on chemotherapy.
- Steroid induced diabetes or patient on chronic or intermittent steroid therapy (use for more than 2 months out of a year)
- Acute or chronic inflammatory or infectious disease process (chronic osteomyelitis, HIV, tuberculosis, bacterial endocarditis)
- End stage renal or liver disease.
- Pregnancy.
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00237094
Start Date
June 1 2005
Last Update
January 15 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Deaconess Billings Clinic Center on Aging
Billings, Montana, United States, 59101